Gilead Sciences (NASDAQ:GILD)

research

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

While the run since the Trump election and now the inauguration has been solid, there are some storm clouds on the horizon. Volatility has drifted to historic lows, while price-to-earnings ...
Read Full Story »
research

Biotech Short Sellers Run for Cover

The short interest data are out for the most recent settlement date, December 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
Test tubes

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

Needless to say, the past two years have been rough on biotech. So rough in fact, that a basket of the largest capitalization stocks now trades with a price-to-earnings growth ...
Read Full Story »
biotech word cloud

Biotech Short Interest Sinks

The short interest data are out for the most recent settlement date, December 15. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
biotech word cloud

Biotech Short Interest Remains Mixed

The short interest data are out for the most recent settlement date, November 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
Stock Price

FitBit, Gilead Sciences in Thursday’s 52-Week Low Club

December 8, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Thursday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
biotech word cloud

Short Sellers Grow More Aggressive on Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
Hepatitis Virus

Gilead Scores Another Hepatitis FDA Approval

The biotech industry had enjoyed years of growth, but the past year was tarnished on the political election rhetoric about drug pricing. If one company had been at the center of criticism, ...
Read Full Story »
biotech word cloud

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
automatic inspection machine

How Analysts View Value and Opportunity in Gilead After Earnings

If you just looked at formal Buy and Sell ratings from Wall Street analysts, you might assume that everything is still fine and hopeful for Gilead Sciences Inc. (NASDAQ: GILD). ...
Read Full Story »
Prescription Drugs, Pills

Has Gilead Finally Bottomed?

Gilead Sciences Inc. (NASDAQ: GILD) released third-quarter earnings report after markets closed on Tuesday. Despite negative news coming out on Tuesday with former presidential candidate Bernie Sanders taking a shot ...
Read Full Story »
biotech word cloud

What to Expect From Gilead Earnings

Gilead Sciences Inc. (NASDAQ: GILD) is scheduled to release its third-quarter financial results after the markets close on Tuesday. The health care sector has been under fire recently, and some ...
Read Full Story »
ThinkstockPhotos-475180302

8 Top Earnings for the Week Ahead

24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. Earnings season is in full swing, when most major companies ...
Read Full Story »
biotech word cloud

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, October 14. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
Pills and tablets

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

It is no secret that the health care system in America needs help. Treatment costs have gone through the roof over the past two decades, and there is an ongoing ...
Read Full Story »